Results 101 to 110 of about 90,654 (272)
Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations
Molecular Genetics and Metabolism ReportsFluoxetine has been identified as a potential treatment for mucopolysaccharidosis IIIA (MPS IIIA), a debilitating and progressive lysosomal storage disorder for which no treatments are approved.
Lindsay Torrice, Elizabeth Jalazo
doaj +1 more source
Frontiers in Human Neuroscience, 2016 The selective serotonin reuptake inhibitor fluoxetine significantly enhances adult visual cortex plasticity within the rat. This effect is related to decreased gamma-aminobutyric acid (GABA) mediated inhibition and identifies fluoxetine as a potential ...
Alice Kitty Lagas +11 more
doaj +1 more source
, 2015 This work reports the isolation and characterization of bacteria from the built environment at Gettysburg College in Gettysburg, PA. Surfaces of a water fountain on campus were swabbed and serially streaked to isolate multiple bacteria on R2A agar ...
DiGeronimo, Kelly J. +3 more
core
Fluoxetine effects assessment on the life cycle of aquatic invertebrates [PDF]
, 2008 International audienceFluoxetine is a serotonin re-uptake inhibitor, generally used as an antidepressant. It is suspected to provoke substantial effects in the aquatic environment.
Fink, G. +7 more
core +4 more sources
‘I, Me, Myself’: Selfhood and Melancholy in the Journals of Gertrude Savile (1697–1758)
Journal for Eighteenth-Century Studies, EarlyView.Abstract This article examines the journals of Gertrude Savile from 1727 in light of recent scholarship on early modern and eighteenth‐century melancholy. The concept had myriad associations with medicine, physiology, the imagination, and feeling, but questions remain about how melancholy during this period was considered by those outside the narrow ...
Daniel Beaumont
wiley +1 more source
Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a Danish register-based cohort study [PDF]
, 2022 Mia Aakjær +6 more
openalex +1 more source
Psychedelics, entactogens and psychoplastogens for depression and related disorders
British Journal of Pharmacology, EarlyView.Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
Frontiers in Cellular Neuroscience, 2014 Fluoxetine is used as a therapeutic agent for autism spectrum disorder (ASD), including Fragile X syndrome (FXS). The treatment often associates with disruptive behaviors such as agitation and disinhibited behaviors in FXS.
Marko eUutela +7 more
doaj +1 more source
Which drugs are most effective for moderate to severe depression in adolescents? [PDF]
, 2008 Fluoxetine is the only selective serotonin-reuptake inhibitor (SSRI) approved by the US Food and Drug Administration (FDA) to treat depression in children 8 years of age and older; it also has the most favorable benefit-to-risk profile compared with ...
Guirguis-Blake, Janelle +2 more
core
Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice [PDF]
Several reports have suggested that early neonatal immune activation adversely influences the hypothalamic– pituitary–adrenal (HPA) axis development in humans and animal models.
امانی, محمد +6 more
core +1 more source